Hims & Hers Health, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 22, 2025: 82.73

Hims & Hers Health, Inc. Enterprise Value to EBITDA (EV/EBITDA) is 82.73 on July 22, 2025, a -53.12% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Hims & Hers Health, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 202.96 on July 22, 2025, which is 145.32% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Hims & Hers Health, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 40.43 on July 22, 2025, which is -51.14% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Hims & Hers Health, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 103.00.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization